Study guide
5.1 Transport Mechanisms: Diffusion, Convection & Ultrafiltration
BONENT Certified Hemodialysis Nurse CHN
Track your progress as you read
Finished sections get a check mark.
1 Exam Orientation
1.1 Current CHN Exam Facts and Study Strategy
2 Chapter 1: Renal Anatomy, Physiology & CKD Pathophysiology
2.1 Nephron Physiology & Endocrine Functions 2.2 Acute Kidney Injury & Chronic Kidney Disease Staging 2.3 Fluid, Electrolyte & Acid-Base Imbalances in ESRD
3 Chapter 2: CKD-MBD, Uremia & Clinical Manifestations
3.1 CKD-Mineral and Bone Disorder (CKD-MBD) 3.2 Uremic Syndrome & Multi-System Complications 3.3 Dialysis Patient Education & Nutritional Management
4 Individualized Nursing Care
4.1 Nursing Assessment, Planning and Evaluation 4.2 Treatment Records and Safe Handoffs 4.3 Psychosocial Assessment, Counseling and Referral
5 Chapter 3: Principles of Hemodialysis & Dialysate Chemistry
5.1 Transport Mechanisms: Diffusion, Convection & Ultrafiltration 5.2 Dialyzer Characteristics, Membrane Biocompatibility & Flux 5.3 Dialysate Composition & Concentrate Formulations 5.4 Hemodialysis Adequacy: Urea Kinetics, Kt/V & URR
6 Chapter 4: Vascular Access: Fistulas, Grafts & Catheters
6.1 Arteriovenous Fistulas & Arteriovenous Grafts 6.2 Physical Examination, Surveillance & Monitoring of Access 6.3 Central Venous Catheters & CDC Infection Prevention
7 Chapter 5: Cannulation Practice & Access Complications
7.1 Cannulation Techniques: Rope-Ladder, Buttonhole & Needle Sizing 7.2 Vascular Access Stenosis, Thrombosis & Steal Syndrome 7.3 Access Infiltration, Pseudoaneurysms & Hemorrhage Management
8 Chapter 6: Hemodialysis Treatment Delivery & Circuit Monitoring
8.1 Pre-Dialysis Assessment, Target Dry Weight & UFR Limits 8.2 Extracorporeal Circuit Setup, Priming & Safety Alarms 8.3 Anticoagulation Management: Heparin Protocols & Citrate 8.4 Treatment Termination, Hemostasis & Post-Dialysis Assessment
9 Equipment and Laboratory Skills
9.1 Ancillary Equipment and Bedside Safety 9.2 Blood Sampling, Laboratory Trends and Critical Results
10 Chapter 7: Acute Intradialytic Complications & Emergencies
10.1 Intradialytic Hypotension & Muscle Cramping 10.2 Dialysis Disequilibrium Syndrome & Neurological Events 10.3 Dialyzer Reactions & Hypersensitivity (Type A and Type B) 10.4 Critical Emergencies: Air Embolism, Hemolysis & Blood Loss
11 Extended and Acute Treatment
11.1 Sequential UF, Hemofiltration and Hemoperfusion 11.2 Acute Kidney Injury and High-Risk Dialysis Initiation
12 Chapter 8: Nephrology Pharmacology in Hemodialysis
12.1 Anemia Management: ESAs & Intravenous Iron Therapy 12.2 CKD-MBD Pharmacotherapy: Binders, Vitamin D & Calcimimetics 12.3 Cardiovascular, Antimicrobial & Dialyzable Drug Dosing
13 Home and Peritoneal Dialysis
13.1 Home Dialysis Selection and Adult Learning 13.2 Home Setup, Monitoring and Emergency Readiness 13.3 Peritoneal Dialysis Principles and Nursing Care
14 Kidney Transplantation
14.1 Transplant Benefits, Burdens and Modality Counseling 14.2 Transplant Indications, Contraindications and Referral 14.3 Pretransplant Workup and Waiting-List Coordination 14.4 Immunosuppressants, Interactions and Patient Teaching 14.5 Returning to Dialysis After Graft Failure 14.6 New-Graft Monitoring and Urgent Changes
15 Chapter 9: Water Treatment Systems & Dialyzer Reprocessing
15.1 AAMI/ISO Water Treatment Architecture & Components 15.2 Chemical Contaminant Monitoring & Total Chlorine Testing 15.3 Microbiological Standards, Endotoxin Surveillance & Sampling 15.4 Dialyzer Reprocessing Standards, Testing & Germicide Safety
16 Clinical Unit Management
16.1 Evaluating Dialysis Technology and Supplies 16.2 Staffing, Personnel Policies and Standards of Care
17 Chapter 10: Supervision, Administration & Professional Practice
17.1 RN Delegation, Technician Supervision & Nurse Practice Acts 17.2 CMS Conditions for Coverage & Interdisciplinary Care Planning 17.3 Dialysis Unit Infection Control & Environmental Safety 17.4 Quality Improvement (ESRD QIP), Ethics & Palliative Care
18 Professional Development
18.1 Professional Literature, Organizations and Continuing Learning 18.2 Research Design, Implementation and Evidence Interpretation 18.3 Staff Training, Competency and Remediation
19 Environmental Hazards and Emergency Planning
19.1 Chemical Agents, Disinfection and Exposure Control 19.2 Biological Hazards and Occupational Injury Response 19.3 Fire, Threats and Power or Water Interruptions
5.1 Transport Mechanisms: Diffusion, Convection & Ultrafiltration
Key Takeaways Explain This Topic AI
Diffusion transfers solute along a concentration gradient; mass transfer and clearance have different units.
Countercurrent flow preserves a useful gradient along the dialyzer.
UF is pressure-driven water transport; volumetric control manages prescribed net removal.
Convection carries dissolved solutes with water, and replacement volume makes total filtration differ from net patient loss.
Last updated: October 2026
Transport Mechanisms: Diffusion, Convection & Ultrafiltration
Extracorporeal blood purification relies on four biophysical transport mechanisms across a semipermeable capillary membrane: diffusion, ultrafiltration, convection, and osmosis. Mastering these physical principles, equations, and operational determinants allows the Certified Hemodialysis Nurse (CHN) to maximize solute clearance, manage fluid removal safely, and troubleshoot circuit malfunctions.
1. Diffusion and Fick's Law of Mass Transfer
Diffusion is the spontaneous net movement of solute particles across a semipermeable membrane from an area of higher concentration to lower concentration down a chemical gradient. In hemodialysis, diffusion provides the primary clearance mechanism for small, water-soluble uremic solutes such as urea (molecular weight 60 Da), creatinine (113 Da), uric acid (168 Da), and potassium ( K + K^+ K + ).
Diffusive solute flux across the dialyzer membrane is governed by Fick's First Law: J = − D d C d x J = -D \frac{dC}{dx} J = − D d x d C
Where:
J J J is solute flux (mass transfer rate per unit surface area).
D D D is the solute diffusion coefficient in the membrane matrix.
d C d x \frac{dC}{dx} d x d C is the solute concentration gradient across membrane thickness ( x x x ).
Clinical Determinants of Diffusive Clearance
Concentration gradient: Solute mass transfer increases with the gradient under fixed conditions. Clearance is a volume/time quantity and differs from mass-transfer rate.
Solute size and permeability: Small solutes generally diffuse more readily than larger molecules. Membrane properties, protein binding and the solute's diffusion coefficient affect transfer.
Membrane geometry: Larger effective surface area and a thinner diffusion path can improve transfer. Product specifications differ; a partly clotted bundle has less functional area than its labeled area.
Blood and dialysate flow: Prescribed flows and flow distribution affect boundary layers and delivery. Increasing a displayed pump setting cannot correct inadequate access inflow or guarantee proportional clearance gains.
Patient and device conditions: Temperature, flow and UF settings follow the individualized prescription and device limits. Assess delivered treatment rather than treating an in-vitro clearance chart as the patient's measured dose.
2. Countercurrent Flow Mechanism
Modern dialyzers position blood and dialysate in a countercurrent configuration: blood flows in one direction through hollow-fiber lumens, while dialysate flows in the opposite direction through the shell space.
Continuous Gradient: Blood entering with the highest solute concentration meets dialysate exiting with partially accumulated solutes, but still with a lower concentration. As blood moves along the fiber and loses solute, it continuously encounters fresher dialysate. At the blood outlet, blood with the lowest solute level meets fresh incoming dialysate. This preserves a driving concentration gradient ( Δ C > 0 \Delta C > 0 Δ C > 0 ) across the full dialyzer length.
Clearance Superiority: Countercurrent flow generally supports greater diffusive transfer than co-current flow under otherwise comparable conditions. The difference depends on the solute, flows and dialyzer design.
Accidental Co-Current Flow: If dialysate lines are connected in reverse, blood and dialysate flow in the same direction. The driving gradient narrows along the dialyzer, reducing transfer efficiency. Verify labeled port connections; do not assume that equilibration always occurs at the midpoint or that the clearance loss is a fixed percentage.
3. Ultrafiltration (UF) and Transmembrane Pressure (TMP)
Ultrafiltration is the hydrostatic pressure-driven movement of plasma water across the semipermeable membrane, removing excess fluid accumulated during the interdialytic period.
Transmembrane Pressure (TMP) represents the net hydrostatic pressure pushing fluid from blood into dialysate: T M P = P b i + P b o 2 − P d i + P d o 2 TMP = \frac{P_{bi} + P_{bo}}{2} - \frac{P_{di} + P_{do}}{2} TMP = 2 P bi + P b o − 2 P d i + P d o
Where P b i , P b o , P d i , P_{bi}, P_{bo}, P_{di}, P bi , P b o , P d i , and P d o P_{do} P d o are blood and dialysate inlet and outlet pressures. This is a simplified mean-pressure estimate, not the display equation for every machine.
Displayed TMP depends on the machine’s sensor arrangement. Interpret it with the manufacturer’s method, circuit observations and prescribed flow rather than a universal two-pressure formula.
Negative dialysate pressure generated by internal pumps pulls water across the membrane. In a simplified hydraulic relationship that neglects oncotic pressure and changing membrane conditions, fluid removal depends on the membrane ultrafiltration coefficient ( K u f K_{uf} K u f , in mL/hr/mmHg \text{mL/hr/mmHg} mL/hr/mmHg ): U F R = K u f × T M P UFR = K_{uf} \times TMP U FR = K u f × TMP
Higher hydraulic permeability permits more filtration at a given effective pressure. Low- and high-flux classification also considers solute performance and is not defined by one universal hydraulic cutoff; compare the actual product specifications.
4. Convection (Solvent Drag) and Sieving Coefficients
Convection occurs when water is pulled across the membrane during ultrafiltration, dragging dissolved solutes along via bulk fluid flow. Convective clearance ( K c K_c K c ) is calculated as: K c = U F R × S K_c = UFR \times S K c = U FR × S
Where S S S is the membrane sieving coefficient: S = C f i l t r a t e C p l a s m a S = \frac{C_{filtrate}}{C_{plasma}} S = C pl a s ma C f i lt r a t e
S = 1.0 S = 1.0 S = 1.0 : Solute passes freely through pores with water (e.g., urea, creatinine).
S = 0.0 S = 0.0 S = 0.0 : The solute is fully retained in this idealized example. Albumin retention is important, but actual albumin loss and sieving vary with membrane design and treatment.
Middle-molecule clearance: Hemofiltration and hemodiafiltration use convection to remove permeable solutes such as β 2 \beta_2 β 2 -microglobulin. High-flux HD can involve diffusion and internal filtration as well. Sieving is product- and solute-specific; total filtration volume, replacement method and membrane properties matter.
5. Osmosis in Dialysis
Osmosis is the net movement of water across a semipermeable membrane from low solute concentration to high solute concentration along an osmotic or oncotic gradient.
Hypertonic infusions: Raising extracellular osmolality can shift water between compartments, but saline or dextrose for symptoms requires a specific order and monitoring. Osmotic reasoning does not make either a routine first-line intervention for all cramps or hypotension.
Hypotonic Dialysate Hazard: If dialysate sodium is inappropriately low, water rushes into erythrocytes and cerebral tissue via osmosis, causing acute hemolysis and cerebral edema.
Transport Mechanism Summary
Mechanism Driving Force Substance Transported Solute Size Range Key Dialyzer Determinants
Diffusion Concentration gradient ( Δ C \Delta C Δ C ) Dissolved solutes (urea, K + K^+ K + ) < 500 Da < 500\text{ Da} < 500 Da Q b Q_b Q b , Q d Q_d Q d , surface area, countercurrent flow
Ultrafiltration Hydrostatic pressure (TMP) Plasma water Solvent Machine volumetric pump, K u f K_{uf} K u f
Convection Bulk fluid solvent drag Middle molecules ( β 2 M \beta_2\text{M} β 2 M ) 500 − 30 , 000 Da 500-30,000\text{ Da} 500 − 30 , 000 Da Ultrafiltration rate (UFR), sieving coefficient ( S S S )
- Osmosis Osmotic gradient ( Δ π \Delta \pi Δ π ) Water molecules Solvent Plasma osmolality, dialysate sodium
- Clinical Nursing Practice Points
Hollow-Fiber Clotting: Clotted fibers reduce surface area and K u f K_{uf} K u f , causing machine TMP to rise as the volumetric system applies greater pressure to achieve target ultrafiltration.
Boundary Layer Shearing: Maintain the prescribed blood flow while assessing access and circuit pressures. A faster setting is not appropriate when withdrawal resistance or patient conditions make delivery unsafe.
Temperature and UF rate follow the individualized prescription and device limits. Plasma refill varies; 13 mL/kg/hour is an observational risk marker, not the patient’s fixed refill capacity.
Units and Device Interpretation
A simplified four-pressure TMP estimate uses mean blood-side pressure minus mean dialysate-side pressure; effective filtration also depends on oncotic pressure. Machines calculate displayed TMP from their available sensors, so one manufacturer’s display cannot be interpreted by substituting a universal venous-minus-dialysate equation. Consult the device instructions and trend the value with circuit appearance, delivered flow and alarms.
For a membrane with a stated hydraulic coefficient of 20 mL/hour/mmHg, a simplified pressure difference of 100 mmHg corresponds to 2,000 mL/hour, not 2,000 mL/minute. Modern volumetric control governs prescribed net removal. Net patient fluid loss is not the entire convective volume in hemodiafiltration, where replacement fluid and internal filtration must also be considered. Solute clearance has units of volume/time, whereas mass removal additionally depends on concentration. Confusing these quantities leads to incorrect adequacy calculations.
Sources checked 2026-10-10: NIDDK HD ; current device and medication instructions govern product-specific details.